Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Capranzano

Showing results (41-50 of 224) with videos related to

Pageof 23
Sort By:
Interventional Cardiology Clinics|June 6, 2017
Combination Antithrombotic Management of STEMI with Pharmacoinvasive Strategy, Primary PCI, or Rescue PCIPiera Capranzano, Corrado Tamburino, George D Dangas
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 29, 2013
Authors' replyPiera Capranzano, Salvatore Scandura, Anna Caggegi, et al.
Giornale Italiano Di Cardiologia (2006)|March 6, 2020
[Management of antithrombotic therapy in patients with bleeding after percutaneous coronary intervention]Piera Capranzano, Bruno Francaviglia, Davide Capodanno, et al.
Expert Review of Cardiovascular Therapy|April 22, 2009
Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary interventionPiera Capranzano, Jose Luis Ferreiro, Dominick J Angiolillo
International Journal of Cardiology|August 25, 2015
Risk stratification for secondary prevention with ticagrelor and aspirin: A closer look to patient subsets from the PEGASUS-TIMI 54 trialDavide Capodanno, Piera Capranzano, Sergio Buccheri, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 31, 2018
Appraisal of key trials in aortic and mitral fieldsPiera Capranzano, Nicolas M Van Mieghem, Corrado Tamburino
International Journal of Cardiology|May 7, 2013
Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary interventionDavide Capodanno, Piera Capranzano, Alessio La Manna, et al.
American Heart Journal|June 7, 2016
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerationsLeonardo De Luca, Piera Capranzano, Giuseppe Patti, et al.
International Journal of Cardiology|July 17, 2016
Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike?Roberta Rossini, Davide Capodanno, Paolo Ferrero, et al.
Expert Review of Cardiovascular Therapy|August 21, 2013
Personalizing oral anticoagulant treatment in patients with atrial fibrillationPiera Capranzano, Eligio Miccichè, Lucia D'Urso, et al.
Pageof 23

Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
Interventional Cardiology Clinics|June 6, 2017
Combination Antithrombotic Management of STEMI with Pharmacoinvasive Strategy, Primary PCI, or Rescue PCIPiera Capranzano, Corrado Tamburino, George D Dangas
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 29, 2013
Authors' replyPiera Capranzano, Salvatore Scandura, Anna Caggegi, et al.
Giornale Italiano Di Cardiologia (2006)|March 6, 2020
[Management of antithrombotic therapy in patients with bleeding after percutaneous coronary intervention]Piera Capranzano, Bruno Francaviglia, Davide Capodanno, et al.
Expert Review of Cardiovascular Therapy|April 22, 2009
Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary interventionPiera Capranzano, Jose Luis Ferreiro, Dominick J Angiolillo
International Journal of Cardiology|August 25, 2015
Risk stratification for secondary prevention with ticagrelor and aspirin: A closer look to patient subsets from the PEGASUS-TIMI 54 trialDavide Capodanno, Piera Capranzano, Sergio Buccheri, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 31, 2018
Appraisal of key trials in aortic and mitral fieldsPiera Capranzano, Nicolas M Van Mieghem, Corrado Tamburino
International Journal of Cardiology|May 7, 2013
Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary interventionDavide Capodanno, Piera Capranzano, Alessio La Manna, et al.
American Heart Journal|June 7, 2016
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerationsLeonardo De Luca, Piera Capranzano, Giuseppe Patti, et al.
International Journal of Cardiology|July 17, 2016
Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike?Roberta Rossini, Davide Capodanno, Paolo Ferrero, et al.
Expert Review of Cardiovascular Therapy|August 21, 2013
Personalizing oral anticoagulant treatment in patients with atrial fibrillationPiera Capranzano, Eligio Miccichè, Lucia D'Urso, et al.
Pageof 23